Overview Financials News + Filings Key Docs Holdings Insiders
|
ALLIANCEBERNSTEIN L.P.
> RVNC
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Revance Therapeutics, Inc. | RVNC | 2,596,263 | 617,706 | 65,711,417,000 | 1,982,096,000 | $25,310.00 |
03/31/2023 | Revance Therapeutics, Inc. | RVNC | 1,978,557 | 1,894,157 | 63,729,321,000 | 62,171,297,000 | $32,210.00 |
12/31/2022 | Revance Therapeutics, Inc. | RVNC | 84,400 | -32,047 | 1,558,024,000 | 1,554,880,000 | $18,460.00 |
09/30/2022 | Revance Therapeutics, Inc. | RVNC | 116,447 | 0 | 3,144,000 | 1,535,000 | $27.00 |
06/30/2022 | Revance Therapeutics, Inc. | RVNC | 116,447 | -27,500 | 1,609,000 | -1,198,000 | $13.82 |
03/31/2022 | Revance Therapeutics, Inc. | RVNC | 143,947 | 200 | 2,807,000 | 461,000 | $19.50 |
12/31/2021 | Revance Therapeutics, Inc. | RVNC | 143,747 | -3,137,848 | 2,346,000 | -89,079,000 | $16.32 |
09/30/2021 | Revance Therapeutics, Inc. | RVNC | 3,281,595 | 193,929 | 91,425,000 | -93,000 | $27.86 |
06/30/2021 | Revance Therapeutics, Inc. | RVNC | 3,087,666 | -265,613 | 91,518,000 | -2,206,000 | $29.64 |
03/31/2021 | Revance Therapeutics, Inc. | RVNC | 3,353,279 | 287,375 | 93,724,000 | 6,836,000 | $27.95 |
12/31/2020 | Revance Therapeutics, Inc. | RVNC | 3,065,904 | 462,388 | 86,888,000 | 21,436,000 | $28.34 |
09/30/2020 | Revance Therapeutics, Inc. | RVNC | 2,603,516 | -189,294 | 65,452,000 | -2,748,000 | $25.14 |
06/30/2020 | Revance Therapeutics, Inc. | RVNC | 2,792,810 | 580,637 | 68,200,000 | 35,460,000 | $24.42 |
03/31/2020 | Revance Therapeutics, Inc. | RVNC | 2,212,173 | 261,198 | 32,740,000 | 1,076,000 | $14.80 |
12/31/2019 | Revance Therapeutics, Inc. | RVNC | 1,950,975 | -122,236 | 31,664,000 | 4,712,000 | $16.23 |
09/30/2019 | Revance Therapeutics, Inc. | RVNC | 2,073,211 | 29,411 | 26,952,000 | 444,000 | $13.00 |
06/30/2019 | Revance Therapeutics, Inc. | RVNC | 2,043,800 | 2,671 | 26,508,000 | -5,660,000 | $12.97 |
03/31/2019 | Revance Therapeutics, Inc. | RVNC | 2,041,129 | 479,937 | 32,168,000 | 741,000 | $15.76 |
12/31/2018 | Revance Therapeutics, Inc. | RVNC | 1,561,192 | -90,757 | 31,427,000 | -9,624,000 | $20.13 |
09/30/2018 | Revance Therapeutics, Inc. | RVNC | 1,651,949 | 341,896 | 41,051,000 | 5,090,000 | $24.85 |
06/30/2018 | Revance Therapeutics, Inc. | RVNC | 1,310,053 | 170,942 | 35,961,000 | 876,000 | $27.45 |
03/31/2018 | Revance Therapeutics, Inc. | RVNC | 1,139,111 | 231,416 | 35,085,000 | 2,635,000 | $30.80 |
12/31/2017 | Revance Therapeutics, Inc. | RVNC | 907,695 | 885,895 | 32,450,000 | 31,849,000 | $35.75 |
09/30/2017 | Revance Therapeutics, Inc. | RVNC | 21,800 | -2,200 | 601,000 | -33,000 | $27.57 |
06/30/2017 | Revance Therapeutics, Inc. | RVNC | 24,000 | 0 | 634,000 | 135,000 | $26.42 |
03/31/2017 | Revance Therapeutics, Inc. | RVNC | 24,000 | -3,800 | 499,000 | -76,000 | $20.79 |
12/31/2016 | Revance Therapeutics, Inc. | RVNC | 27,800 | -1,600 | 575,000 | 98,000 | $20.68 |
09/30/2016 | Revance Therapeutics, Inc. | RVNC | 29,400 | 29,400 | 477,000 | 477,000 | $16.22 |
06/30/2016 | Revance Therapeutics, Inc. | RVNC | 35,300 | 35,300 | 480,000 | 480,000 | $13.60 |
03/31/2016 | Revance Therapeutics, Inc. | RVNC | 25,300 | 0 | 442,000 | -422,000 | $17.47 |
12/31/2015 | Revance Therapeutics, Inc. | RVNC | 25,300 | 25,300 | 864,000 | 864,000 | $34.15 |
09/30/2015 | Revance Therapeutics, Inc. | RVNC | 22,200 | 22,200 | 661,000 | 661,000 | $29.77 |
06/30/2015 | Revance Therapeutics, Inc. | RVNC | 19,900 | 19,900 | 636,000 | 636,000 | $31.96 |
03/31/2015 | Revance Therapeutics, Inc. | RVNC | 7,200 | -568,706 | 149,000 | -9,607,000 | $20.69 |
12/31/2014 | Revance Therapeutics, Inc. | RVNC | 575,906 | 575,906 | 9,756,000 | 9,756,000 | $16.94 |
<< Prev Next >> |
|